AHCO - AdaptHealth Corp.

QQQ $ 612.50 $ -11.61 (-1.86 %)

DIA $ 469.77 $ -3.83 (-0.81 %)

SPY $ 671.27 $ -7.27 (-1.07 %)

TLT $ 89.75 $ 0.80 (0.9 %)

GLD $ 366.12 $ -0.44 (-0.12 %)

Previous Close

$ 9.61

Open

$ 10.07

Bid

$ 9.45 x 1

Ask

$ 11.00 x 1

Day's Range

$ 9.57 - $ 10.35

52 Week Range

$ 7.11 - $ 11.63

Volume

1,121,822

Average Volume

Market Cap

1.3B

Beta (5Y Monthly)

$ 0.98

PE Ratio (TTM)

$ 15.83

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-04-2025	09-30-2025	10-Q
2	08-05-2025	06-30-2025	10-Q
3	05-06-2025	03-31-2025	10-Q
4	02-25-2025	12-31-2024	10-K
5	11-05-2024	09-30-2024	10-Q
6	08-06-2024	06-30-2024	10-Q
7	05-07-2024	03-31-2024	10-Q
8	02-27-2024	12-31-2023	10-K
9	11-07-2023	09-30-2023	10-Q
10	08-08-2023	06-30-2023	10-Q
11	05-09-2023	03-31-2023	10-Q
12	02-28-2023	12-31-2022	10-K
13	11-08-2022	09-30-2022	10-Q
14	08-09-2022	06-30-2022	10-Q
15	05-10-2022	03-31-2022	10-Q
16	03-01-2022	12-31-2021	10-K
17	11-09-2021	09-30-2021	10-Q
18	08-06-2021	06-30-2021	10-Q
19	05-10-2021	03-31-2021	10-Q
20	03-16-2021	12-31-2020	10-K
21	11-06-2020	09-30-2020	10-Q
22	08-07-2020	06-30-2020	10-Q
23	05-08-2020	03-31-2020	10-Q
24	03-06-2020	12-31-2019	10-K
25	11-05-2019	09-30-2019	10-Q
26	07-31-2019	06-30-2019	10-Q
27	05-14-2019	03-31-2019	10-Q
28	03-29-2019	12-31-2018	10-K
29	11-08-2018	09-30-2018	10-Q
30	08-08-2018	06-30-2018	10-Q
31	05-15-2018	03-31-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Canaccord Genuity Maintains Buy on AdaptHe...
11/06/2025 19:55:44

Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $14 ...

AdaptHealth Affirms FY2025 Sales Guidance ...
11/04/2025 12:07:06

AdaptHealth (NASDAQ:AHCO) affirms FY2025 sales outlook from $3.180 billion-$3.260 billion to $3.180 billion-$3.260 billion vs $...

AdaptHealth Q3 EPS $0.16 Misses $0.23 Esti...
11/04/2025 12:06:23

AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.23 b...

Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

10 Health Care Stocks Whale Activity In To...
08/13/2025 17:35:30

Adapthealth Announced An Agreement With A ...
08/05/2025 11:08:20

AdaptHealth Narrows FY2025 Sales Guidance ...
08/05/2025 11:06:14

Financial OutlookThe Company is updating previous financial guidance for fiscal year 2025, as follows:Net revenue of $3.18 bill...

AdaptHealth Q2 2025 EPS $0.10 Misses $0.13...
08/05/2025 11:04:10

Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

AdaptHealth Closes Disposition Of Certain ...
06/30/2025 20:14:10

AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-center...

Concentrix Posts Downbeat Earnings, Joins ...
06/27/2025 13:09:54

Truist Securities Maintains Buy on AdaptHe...
05/12/2025 18:00:21

Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $1...

RBC Capital Maintains Outperform on AdaptH...
05/08/2025 16:54:50

RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $14 t...

AdaptHealth Lowers FY2025 Sales Guidance F...
05/06/2025 11:10:46

Financial OutlookThe Company is updating previous financial guidance for fiscal year 2025 to account for the disposition of cer...

AdaptHealth Q1 EPS $(0.05) Misses $0.04 Es...
05/06/2025 11:06:35

AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.04 b...

Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

Baird Maintains Outperform on AdaptHealth,...
02/27/2025 12:41:41

Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $14 to $16.

4 Analysts Assess AdaptHealth: What You Ne...
02/26/2025 20:01:29

Canaccord Genuity Maintains Buy on AdaptHe...
02/26/2025 16:55:07

Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $13 ...

RBC Capital Maintains Outperform on AdaptH...
02/26/2025 16:34:10

RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $11 t...